BEACON-CRC: first-line bevacizumab in colorectal cancer treatment
BEACON-CRC: first-line bevacizumab in colorectal cancer treatment
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer
Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer